Table 3 Allele frequency distribution of polymorphic genetic variants by breast cancer status at follow-up
IGF1 genotype | All women ( n =254) | No breast cancer ( n =248) | Breast cancer ( n =6) |
|---|---|---|---|
(VNTR) | No. (%) | No. (%) | No. (%) |
12 | 3 (0.6%) | 2 (0.4%) | 1 (8.3%) |
13 | — | — | — |
14 | — | — | — |
15 | — | — | — |
16 | — | — | — |
17 | 8 (1.6%) | 8 (1.6%) | — |
18 | 32 (6.3%) | 32 (6.5%) | — |
19 | 333 (65.6%) | 330 (66.5%) | 3 (25.0%) |
20 | 91(17.9%) | 87 (17.5%) | 4 (33.3%) |
21 | 35 (6.9%) | 32 (6.5%) | 3 (25.0%) |
22 | 6 (1.2%) | 5 (1.0%) | 1 (8.3%) |
IGF1 19-repeat allele | |||
Absent | 33 (13.0%) | 29 (11.7%) | 4 (66.7%) |
Present | 221 (87.0%) | 219 (88.3%) | 2 (33.3%) |
